Leverage Shares 2X Long FIX Daily ETF (BATS:FIXX) CEO Sells $26,798.72 in Stock

Leverage Shares 2X Long FIX Daily ETF (BATS:FIXX) CEO Jodie Pope Morrison sold 3,221 shares of the company’s stock in a transaction on Tuesday, October 6th. The shares were sold at an average price of $8.32, for a total transaction of $26,798.72. Following the sale, the chief executive officer directly owned 340,038 shares in the company, valued at approximately $2,829,116.16. The trade was a 0.94% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Jodie Pope Morrison also recently made the following trade(s):

• On Tuesday, August 25th, Jodie Pope Morrison sold 9,845 shares of Leverage Shares 2X Long FIX Daily ETF stock. The shares were sold at an average price of $16.56, for a total transaction of $163,033.20.

Leverage Shares 2X Long FIX Daily ETF Trading Down 10.9%

FIXX stock traded down $1.35 during trading on Wednesday, hitting $11.01. 2,492 shares of the company’s stock traded hands, compared to its average volume of 2,920. Leverage Shares 2X Long FIX Daily ETF has a 52 week low of $11.00 and a 52 week high of $15.92.

Homology Medicines, Inc was a clinical-stage biotechnology company focused on developing genetic medicines for patients with rare diseases. The company sought to use its proprietary human-derived adeno-associated virus vectors, known as AAVHSCs, to deliver gene therapies in vivo and address the underlying causes of inherited disorders.

Its development programs included HMI-103, an investigational gene therapy for phenylketonuria, as well as earlier programs targeting other rare diseases.